Asghar, K. and Loya, A. (2018) “INDOLEAMINE 2,3 DIOXYGENASE AS AN IMMUNOTHERAPEUTIC TARGET BRINGS A NEW HOPE FOR CANCER PATIENTS”, Journal of Cancer & Allied Specialties, 4(3). doi: 10.37029/jcas.v4i3.175.